281 filings
Page 6 of 15
4
v1joqeo
2 Mar 22
Galera Therapeutics / Mark Bachleda ownership change
4:05pm
4
x7nrinw3zlj4jj
2 Mar 22
Galera Therapeutics / Mel Sorensen ownership change
4:05pm
SC 13G/A
shd6 dx11
14 Feb 22
Galera Therapeutics / CITADEL ADVISORS ownership change
6:26am
SC 13G
afflup96plgd8jvz
11 Feb 22
Galera Therapeutics / Rosalind Advisors ownership change
5:14pm
SC 13G/A
lhbzlypthy 6r3xs4
11 Feb 22
Galera Therapeutics / Novartis Bioventures ownership change
4:30pm
SC 13G/A
ai02p0
11 Feb 22
Galera Therapeutics / Blackstone Holdings I/II GP L.L.C. ownership change
6:11am
SC 13G/A
hsjqu
10 Feb 22
Galera Therapeutics / ADAGE CAPITAL PARTNERS GP, L.L.C. ownership change
8:48am
SC 13G/A
9aomipst5wbn
2 Feb 22
Galera Therapeutics / Novo Holdings A/S ownership change
4:55pm
SC 13G
7hgsrp3w730qjzw0gr
27 Dec 21
Galera Therapeutics / CITADEL ADVISORS ownership change
4:12pm
4
pi8dfuk
20 Dec 21
Galera Therapeutics / Linda West ownership change
6:30pm
4
skb zg3ddb
20 Dec 21
Galera Therapeutics / Robert A Beardsley ownership change
6:30pm
8-K
n2zc4hd psca87h4f
14 Dec 21
Galera Announces Primary Endpoint Met Statistical Significance in Corrected
7:06am
8-K
lj8lve n96o
10 Nov 21
Galera Reports Third Quarter 2021 Financial Results and Recent Corporate Updates
7:07am
SC 13G/A
zzdmx9xbai63 d1j
20 Oct 21
Galera Therapeutics / HIRSCHMAN ORIN ownership change
3:42pm
8-K
l1imrccqv1
19 Oct 21
Galera Announces Results of Phase 3 ROMAN Trial of Avasopasem for Radiotherapy-Induced Severe Oral Mucositis
7:05am
4
1ewnpcxv
12 Oct 21
Galera Therapeutics / Mark Bachleda ownership change
8:23pm
4
8dkk2nnlvhcl y38
12 Oct 21
Galera Therapeutics / Jennifer Evans Stacey ownership change
8:20pm
3
38rquibe9prg29lujk9q
12 Oct 21
Galera Therapeutics / Mark Bachleda ownership change
8:18pm
3
v7rdk8ackyw3h3a4
12 Oct 21
Galera Therapeutics / Jennifer Evans Stacey ownership change
8:15pm